Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies.

Emanuela Palmerini,John H Healey,Nicholas M Bernthal,Sebastian Bauer,Hendrik Schreuder,Andreas Leithner,Javier Martin-Broto,Francois Gouin,Julio Lopez-Bastida,Hans Gelderblom,Eric L Staals,Florence Mercier,Petra Laeis,Xin Ye,Michiel van de Sande

The oncologist（2023）

引用 1|浏览35

暂无评分

摘要

These findings highlight the impact D-TGCT has on patient quality of life, and how treatment strategies may be influenced by these outcome measures. (ClinicalTrials.gov number: NCT02948088).

查看译文

关键词

diffuse-TGCT,patient-reported outcome (PRO),pexidartinib,prospective,quality of life (QoL),tenosynovial giant cell tumor observational platform project (TOPP)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要